Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinitis pigmentosa in which the cause of the disease is a mutation in the EYS gene.
Features include rarely findings: Posterior subcapsular cataract and Chorioretinal atrophy. 10 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Optic disc pallor, Posterior subcapsular cataract, Attenuation of retinal blood vessels |
EYS encodes EGF-like photoreceptor maintenance factor (3,165 aa). Required to maintain the integrity of photoreceptor cells. Highest expression in Testis (1.0 TPM) and Brain Cerebellum (0.3 TPM).
Retinitis pigmentosa 25 is associated with mutations in the EYS gene on chromosome 6.
The EYS protein participates in Essential pentosuria, Defective DCXR does not reduce L-xylulose to xylitol, and DCXR tetramer reduces L-xylulose to xylitol pathways.
EYS is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for EYS is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 25 has been reported in the published literature.
No clinical trials have been registered for retinitis pigmentosa 25.
43 publications have been identified in PubMed for retinitis pigmentosa 25. Research spans Epidemiology / Natural History (35%), Basic Science / Preclinical (21%), and Case Report / Case Series (16%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 15 | 35% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 11:56 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
1 |
Bone spicule pigmentation of the retina |
Muscles | 1 | Chorioretinal atrophy |
Laboratory research
9 |
21% |
Patient case studies | 7 | 16% |
Testing and diagnosis research | 4 | 9% |
New treatment approaches | 4 | 9% |
Research summaries | 2 | 5% |
Other research | 1 | 2% |
Clinical study results | 1 | 2% |
Hong YJ (2026). [PMID: 41457516](https://pubmed.ncbi.nlm.nih.gov/41457516/). *Ann Lab Med*. [Epidemiology / Natural History]
Goddaer S (2026). [PMID: 41606207](https://pubmed.ncbi.nlm.nih.gov/41606207/). *Drug Deliv Transl Res*. [Gene Therapy / Novel Therapeutics]
Kaukonen M (2026). [PMID: 41582090](https://pubmed.ncbi.nlm.nih.gov/41582090/). *Ophthalmic Genet*. [Case Report / Case Series]
Barthelemy N (2026). [PMID: 42011331](https://pubmed.ncbi.nlm.nih.gov/42011331/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Isla-Magrané H (2026). [PMID: 41638056](https://pubmed.ncbi.nlm.nih.gov/41638056/). *Stem Cell Res*. [Other]
Rhee KD (2026). [PMID: 41714294](https://pubmed.ncbi.nlm.nih.gov/41714294/). *Hum Gene Ther*. [Gene Therapy / Novel Therapeutics]
Kim J (2026). [PMID: 42001345](https://pubmed.ncbi.nlm.nih.gov/42001345/). *Hum Cell*. [Basic Science / Preclinical]
Taniguchi M (2026). [PMID: 42098217](https://pubmed.ncbi.nlm.nih.gov/42098217/). *Sci Rep*. [Epidemiology / Natural History]
Muto K (2026). [PMID: 41933129](https://pubmed.ncbi.nlm.nih.gov/41933129/). *Sci Rep*. [Epidemiology / Natural History]
Woof WA (2025). [PMID: 39896422](https://pubmed.ncbi.nlm.nih.gov/39896422/). *Ophthalmol Sci*. [Epidemiology / Natural History]